logo
  

Schibsted Enters Agreement With Polaris To Assume Full Ownership And Control Of FINN

Schibsted ASA (SBSNF.PK) has signed an agreement to acquire 9.99% of Finn.no AS or FINN from Polaris Media ASA. The total transaction value is 2.5 billion Norwegian Kroner on an equity basis. Schibsted will settle the deal by issuance of new Schibsted B-shares to
the seller. Polaris has been a minority owner in FINN since its incorporation in 2000.

Kristin Skogen Lund, CEO of Schibsted, said: "This is another step towards simplifying
Schibsted's structure and unlocking the company's full potential, following the
divestment of our news media operations to the Tinius Trust which was announced
in December last year."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Novartis AG (NVS) Thursday announced that the FDA has granted Breakthrough Therapy designation to Scemblix for treating adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia or CML in chronic phase. This is the third Breakthrough Therapy designation assigned to... The U.S. Consumer Product Safety Commission or CPSC has announced recalls including utility vehicles or UTVs and snowmobiles, as well as electric wall ovens, spin swivel chairs, toy pinwheels, and children's nightgowns citing various reasons. Augusta, Georgia-based Textron Specialized Vehicles is recalling Prowler Pro and Tracker UTVs citing fire risk, as well as Arctic Cat Model Year 2024... Texas Pecan Co. is recalling various nuts, snack mixes, seeds, and snack sticks in 1 Lb and 8 oz sizes, citing the potential to contain undeclared peanut, tree nuts, soy, milk, sesame, and wheat allergens, according to the U.S. Food and Drug Administration.

This week, we feature J&J’s Talc litigation closure,Emergent’s strategic changes for growth ,Pfizer’s breakthrough hemophilia B gene therapy approval,Novartis’s strategic Mariana Oncology Buyout, and Beyfortus Breakthrough RSV prevention.

View More Videos
RELATED NEWS
Follow RTT